Skip to main content
HR 171 118th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Department of Justice Drug trafficking and controlled substances Licensing and registrations Research administration and funding

HALT Fentanyl Act

Introduced: January 9, 2023 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 20, 2023
Referred to the Subcommittee on Health.
Jan 9, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 9, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
What's happening now January 20, 2023

Referred to the Subcommittee on Health.

 Related & companion bills 6
  • HR 568 Related bill SAFE Act
  • S 600 Related bill Stopping Overdoses of Fentanyl Analogues Act
  • HR 1580 Related bill CEASE Overdose Act of 2023
  • HR 3629 Related bill Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • HR 467 Identical bill HALT Fentanyl Act
  • S 1141 Identical bill HALT Fentanyl Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Republican 2
R
Finstad, Brad
Minnesota · Feb 1, 2023
 R
Latta, Robert E.
Ohio · Jan 9, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 171: HALT Fentanyl Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-171/
MLA
"H.R. 171: HALT Fentanyl Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-171/.
Bluebook (legal)
H.R. 171, 118th Cong. (2026), https://openamerica.io/bill/118-HR-171/.
Markdown link
[H.R. 171: HALT Fentanyl Act](https://openamerica.io/bill/118-HR-171/)
Report a problem